Evidence map›Paper›PMID 42574052›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Cobalt-Catalyzed Asymmetric Construction of Boron Stereocenters With C-N Axial Chirality.

Subramani Kumaran, Harihara Subramanian Ravi Sankar, Pritam Maity, J Richard Premkumar, Abir Das, Basker Sundararaju

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cobalt-Catalyzed Asymmetric Construction of Boron Stereocenters With C-N Axial Chirality.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Subramani KumaranDepartment of Chemistry, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India.
Harihara Subramanian Ravi SankarDepartment of Chemistry, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India.
Pritam MaityDepartment of Chemistry, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India.
J Richard PremkumarPG & Research Department of Chemistry, Bishop Heber College, Tiruchirappalli, Tamil Nadu, India.ORCID https://orcid.org/0000-0001-6975-2065
Abir DasDepartment of Chemistry, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India.
Basker SundararajuDepartment of Chemistry, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India.ORCID https://orcid.org/0000-0003-1112-137X

Funding

ANRF ANRF/ARG/2025/002751/CS
6 · The paper itself

Abstract

The efficient construction of boron stereogenic centers alongside axial chirality remains a significant synthetic challenge, particularly under one-pot conditions. Herein, we report a cobalt/Salox-catalyzed enantioselective annulation strategy that enables the simultaneous formation of B-stereogenic frameworks and a C─N chiral axis via C─H and N─H annulation of arylamides with dialkynylborons. This protocol achieves asymmetric desymmetrization at boron along with effective diastereocontrol on the C─N axis under mild conditions. A wide range of aryl amides and alkynes are well tolerated, delivering structurally diverse products in good yields with consistently high diastereo- and enantioselectivities. Mechanistic studies, including control experiments and isotope labelling, provide insight into the reaction pathway and the origin of stereocontrol. The resulting chiral boron-containing compounds exhibit notable fluorescence, and their photophysical properties suggest potential utility in optoelectronic applications.

Indexed as

asymmetric catalysisatropisomersboroncobalt

Identifiers

PMID42574052
PMCPMC13456068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.